354 related articles for article (PubMed ID: 25228295)
21. Newer approaches in topical combination therapy for acne.
Fu LW; Vender RB
Skin Therapy Lett; 2011 Oct; 16(9):3-6. PubMed ID: 22089505
[TBL] [Abstract][Full Text] [Related]
22. Strategic Targets in Acne: The Comedone Switch in Question.
Saurat JH
Dermatology; 2015; 231(2):105-11. PubMed ID: 26113292
[TBL] [Abstract][Full Text] [Related]
23. From pathogenesis of acne vulgaris to anti-acne agents.
Cong TX; Hao D; Wen X; Li XH; He G; Jiang X
Arch Dermatol Res; 2019 Jul; 311(5):337-349. PubMed ID: 30859308
[TBL] [Abstract][Full Text] [Related]
24. [What's new concerning the pathophysiology of acne?].
Auffret N
Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 2):101-6. PubMed ID: 12605138
[No Abstract] [Full Text] [Related]
25. Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes.
Yoon JY; Kwon HH; Min SU; Thiboutot DM; Suh DH
J Invest Dermatol; 2013 Feb; 133(2):429-40. PubMed ID: 23096708
[TBL] [Abstract][Full Text] [Related]
26. [Acne. Current pathophysiologic considerations].
Degitz K; Ochsendorf F
Hautarzt; 2008 Jun; 59(6):503-12; quiz 511. PubMed ID: 18488182
[TBL] [Abstract][Full Text] [Related]
27. The pathogenesis of acne.
Knor T
Acta Dermatovenerol Croat; 2005; 13(1):44-9. PubMed ID: 15788147
[TBL] [Abstract][Full Text] [Related]
28. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance?
Kinney MA; Yentzer BA; Fleischer AB; Feldman SR
J Drugs Dermatol; 2010 May; 9(5):519-24. PubMed ID: 20480795
[TBL] [Abstract][Full Text] [Related]
29. Treating cystic and conglobate acne with 13-cis-retinoic acid.
Yesudian PD
Clin Exp Dermatol; 2020 Dec; 45(8):1109-1110. PubMed ID: 32789894
[No Abstract] [Full Text] [Related]
30. [Acne and its treatment possibilities].
Böni R; Hafner J; Krasovec M
Schweiz Med Wochenschr; 1999 Oct; 129(41):1496-503. PubMed ID: 10555254
[TBL] [Abstract][Full Text] [Related]
31. Acne and Propionibacterium acnes.
Bojar RA; Holland KT
Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
[TBL] [Abstract][Full Text] [Related]
32. Propionibacterium: resistance of acne to antibiotics.
Oakley A; Rademaker M; Duffill M; Leng R; Shewan J
N Z Med J; 1995 Feb; 108(993):43-4. PubMed ID: 7891939
[No Abstract] [Full Text] [Related]
33. A is for acne.
Cornell DH
N J Med; 1999 Jun; 96(6):25-7. PubMed ID: 10384763
[TBL] [Abstract][Full Text] [Related]
34. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies.
Dessinioti C; Katsambas AD
Clin Dermatol; 2010; 28(1):2-7. PubMed ID: 20082942
[TBL] [Abstract][Full Text] [Related]
35. Acne and sebaceous gland function.
Zouboulis CC
Clin Dermatol; 2004; 22(5):360-6. PubMed ID: 15556719
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of acne vulgaris: recent advances.
Bhambri S; Del Rosso JQ; Bhambri A
J Drugs Dermatol; 2009 Jul; 8(7):615-8. PubMed ID: 19588637
[TBL] [Abstract][Full Text] [Related]
37. Analysis of distribution patterns of Propionibacterium acnes phylotypes and Peptostreptococcus species from acne lesions.
Kwon HH; Yoon JY; Park SY; Suh DH
Br J Dermatol; 2013 Nov; 169(5):1152-5. PubMed ID: 23795647
[TBL] [Abstract][Full Text] [Related]
38. Acne: current concepts of pathogenesis and approach to rational treatment.
Eichenfield LF; Leyden JJ
Pediatrician; 1991; 18(3):218-23. PubMed ID: 1835004
[TBL] [Abstract][Full Text] [Related]
39. Acne. Pathogenesis and treatment.
Mescon H; Kohn SR
Minn Med; 1974 Oct; 57(10):788-92. PubMed ID: 4278415
[No Abstract] [Full Text] [Related]
40. Acne vulgaris.
Wilson BB
Prim Care; 1989 Sep; 16(3):695-712. PubMed ID: 2529576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
